Teleflex Incorporated (TFX) Director George Babich, Jr. Sells 2,500 Shares

Teleflex Incorporated (NYSE:TFX) Director George Babich, Jr. sold 2,500 shares of the company’s stock in a transaction dated Tuesday, January 16th. The shares were sold at an average price of $263.38, for a total transaction of $658,450.00. Following the completion of the transaction, the director now directly owns 10,583 shares of the company’s stock, valued at $2,787,350.54. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Teleflex Incorporated (NYSE TFX) opened at $272.31 on Thursday. The company has a debt-to-equity ratio of 0.88, a quick ratio of 3.70 and a current ratio of 4.72. Teleflex Incorporated has a 12-month low of $162.79 and a 12-month high of $272.46. The company has a market cap of $12,270.00, a PE ratio of 49.15, a PEG ratio of 1.94 and a beta of 1.09.

Teleflex (NYSE:TFX) last issued its quarterly earnings results on Thursday, November 2nd. The medical technology company reported $2.12 EPS for the quarter, topping the consensus estimate of $2.01 by $0.11. Teleflex had a net margin of 12.41% and a return on equity of 16.27%. The business had revenue of $534.70 million for the quarter, compared to analysts’ expectations of $522.94 million. During the same quarter last year, the company posted $1.80 earnings per share. The company’s quarterly revenue was up 17.3% compared to the same quarter last year. research analysts forecast that Teleflex Incorporated will post 8.36 EPS for the current fiscal year.

A number of equities analysts have weighed in on the stock. Stephens reissued a “buy” rating and issued a $300.00 price objective on shares of Teleflex in a research report on Thursday. Morgan Stanley upped their price objective on shares of Teleflex from $274.00 to $290.00 and gave the company an “equal weight” rating in a research report on Friday, November 3rd. Piper Jaffray Companies assumed coverage on shares of Teleflex in a research report on Friday, November 10th. They issued an “overweight” rating and a $295.00 price objective for the company. ValuEngine cut shares of Teleflex from a “buy” rating to a “hold” rating in a research report on Friday, December 1st. Finally, Jefferies Group upped their price objective on shares of Teleflex from $270.00 to $295.00 and gave the company a “buy” rating in a research report on Friday, November 3rd. One analyst has rated the stock with a sell rating, five have given a hold rating and six have issued a buy rating to the company. The stock has a consensus rating of “Hold” and an average target price of $277.78.

Several hedge funds have recently modified their holdings of the company. Atlanta Capital Management Co. L L C lifted its position in shares of Teleflex by 2.6% during the second quarter. Atlanta Capital Management Co. L L C now owns 2,519,464 shares of the medical technology company’s stock worth $523,444,000 after purchasing an additional 64,985 shares during the last quarter. Janus Henderson Group PLC lifted its position in shares of Teleflex by 50,429.2% during the second quarter. Janus Henderson Group PLC now owns 1,816,020 shares of the medical technology company’s stock worth $377,296,000 after purchasing an additional 1,812,426 shares during the last quarter. State Street Corp lifted its position in shares of Teleflex by 1.8% during the second quarter. State Street Corp now owns 1,399,922 shares of the medical technology company’s stock worth $290,853,000 after purchasing an additional 25,401 shares during the last quarter. American Century Companies Inc. lifted its position in shares of Teleflex by 41.6% during the third quarter. American Century Companies Inc. now owns 1,187,909 shares of the medical technology company’s stock worth $287,438,000 after purchasing an additional 348,829 shares during the last quarter. Finally, Koch Industries Inc. raised its stake in Teleflex by 47,174.3% during the second quarter. Koch Industries Inc. now owns 959,669 shares of the medical technology company’s stock worth $955,000 after acquiring an additional 957,639 shares during the period. 89.29% of the stock is currently owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY NOTICE: This report was first reported by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this report on another website, it was copied illegally and reposted in violation of US & international trademark & copyright legislation. The original version of this report can be accessed at https://stocknewstimes.com/2018/01/18/teleflex-incorporated-tfx-director-george-babich-jr-sells-2500-shares.html.

Teleflex Company Profile

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).

Insider Buying and Selling by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply